unknown
Stage
About
Biomoneta develops air decontamination technology that eliminates airborne pathogens, including multidrug-resistant bacteria and viruses, to prevent infections in healthcare, pharmaceutical, and biotech environments.
Explore Biomoneta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.